Definitive Contract HHSN261201200093C

<p>This is a $199,386 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Sensopath Technologies, Inc., a woman-owned small business. The contract is for &quot;TAS::75 0849::TAS TARGETED TWO-PHOTON PHOTODYNAMIC THERAPY TRIADS&quot; and has a period of performance through July 8, 2011. The contract was set aside for small businesses.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...

This is a $454,997 fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Ambay Immune Sensors And Controls, LLC, a woman-owned small business. The contract was awarded under the FY20 SBIR Phase I solicitation and is for the development of a &quot;non-invasive, novel test to monitor biological response to radiotherapy&quot; under Topic #400 - AMBAY RADI-SENSE. The contract...

<p>The National Cancer Institute (NCI) awarded a Small Business Innovation Research (SBIR) Phase I contract to Sevident, Inc., a woman-owned small business, for the amount of $299,338. The contract has a firm-fixed price and is set aside for small businesses. The contract is for the SEVIDENT, INC.:1242717 [16-064431] SBIR PHASE I TOPIC, with a performance period ending on June 18, 2017. The contract was awarded on September 19, 2016.</p>

This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...

<p>The National Cancer Institute (NCI) awarded a $199,996.00 Firm Fixed Price contract to Operational Technologies Corporation, a minority-owned, small disadvantaged, veteran-owned business, for Research &amp; Development in Biomedical Basic Research. The contract has a completion date of June 22, 2014 and was set aside for small businesses. As a civilian agency, the NCI focuses on cancer research and this contract contributes to their broader medical research initiatives.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&amp;D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...

This is a $182,050 firm fixed price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanoivd, Inc., a small disadvantaged, woman-owned business. The contract is for TAS::75 0849::TAS and has a total small business set-aside designation. The period of performance runs from the award date of September 30, 2010 through the ultimate completion date of March 30, 2011. Nanoivd, Inc. is the prime contractor, and no subcontractors are mentioned. The contract...

This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract is for the development of glycosylation-specific research under SBIR Topic 294, with a ceiling value of $148,569. SBIR contracts are set-aside for small businesses to engage in research and development for the government. This Phase I contract represents the initial research and feasibility...